abcdefghijklmn
opqrstuvwxyz
Test Menu
Test Change Details
Allergy & Immunology
Cardiology & Coagulation
Dermatopathology
Endocrinology
Gastroenterology
Genetics
Hepatology
Infectious Disease
Microbiology
Nephrology
Neurology
Oncology
Pathology
Pediatrics
Rheumatology
Toxicology
Urology
Women's Health
16296: Rufinamide Print View
Rufinamide LC/MS/MS    mcg/mL 

PRIMARY
1 Serum Red Top 1 (0.5) mL   Room Temperature - 7 Day(s)/Refrigerated - 30 Day(s)/Frozen - 30 Day(s)  
ALTERNATE
  Plasma EDTA 1 (0.5) mL   Frozen - 30 Day(s)/Refrigerated - 30 Day(s)/Room Temperature - 7 Day(s)  

Rufinamide is an antiepileptic indicated for adjunctive treatment of seizures associated with Lennox-Gastaut syndrome in children and adults. As multiple antiepileptics may be administered, it may be important to (1) optimize therapy, (2) monitor compliance, and (3) avoid toxicity.

A trough specimen is preferred. Collect sample within 1 hour prior
to next dose.

Transport temperature: Room temperature
Setup Schedule
Wednesday, Saturday

Reported (Analytical Time)
Next day


Notes
Reject Criteria: Serum separator tubes






1996 - 2017 Quest Diagnostics Nichols Institute of Valencia
For test information, please call Client Services at 800-421-4449.

San Francisco Web Design & Database